INSIDER · CIK 1897618
Karlin Daniel
Chief Medical Officer, Director at Definium Therapeutics, Inc. (DFTX)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$397KSold on the market
1Companies
Sep 29, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202621:15 | Sep 25, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Medical Officer, Director | S · Sell10b5-1 | $36.57 | −10,853 | 792,846 | -1% | −$397K | ||
| Sep 14, 202608:30 | Sep 14, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Medical Officer | A · Grant | — | +200,000 | 803,699 | +33% | — | ||
| Aug 12, 202608:30 | Aug 12, 2026 | DFTXDefinium Therapeutics, Inc. | Chief Medical Officer | A · Grant | — | +100,000 | 603,282 | +20% | — |